Ocugen (OCGN) Other Working Capital Changes (2014 - 2026)
Ocugen's (OCGN) quarterly Other Working Capital Changes came in at -$317000.0 in Q1 2026, down 62.56% YoY from -$846780.8 in Q1 2025, and up 75.93% on a QoQ basis from -$1.3 million in Q4 2025.
Ocugen (OCGN) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 7 years of Other Working Capital Changes data on file, last reported at -$317000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 62.56% year-over-year to -$317000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 51.74% YoY) and the FY2025 annual result came in at -$1.2 million, down 47.3% from the prior year.
- Other Working Capital Changes grew to -$317000.0 in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.0 million in Q1 2025 to a low of -$1.8 million in Q3 2022.
- A 5-year average of $198705.9 and a median of $117000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 3350.0% — and 2025, when it surged 273.67%.
- Tracing OCGN's Other Working Capital Changes over 5 years: stood at -$122000.0 in 2022, then slipped by 10.66% to -$135000.0 in 2023, then slumped by 60.0% to -$216000.0 in 2024, then tumbled by 509.72% to -$1.3 million in 2025, then surged by 75.93% to -$317000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$317000.0 (Q1 2026), -$1.3 million (Q4 2025), and $686000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27,000.00 |
| Jun 30, 2026 | -27,000.00 |
| Jun 30, 2026 | -27,000.00 |
| Mar 31, 2026 | 927,000.00 |
| Mar 31, 2026 | 927,000.00 |
| Mar 31, 2026 | 927,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Sep 30, 2025 | -795,000.00 |
| Sep 30, 2025 | -795,000.00 |
| Sep 30, 2025 | -795,000.00 |
| Jun 30, 2025 | -294,000.00 |
| Jun 30, 2025 | -294,000.00 |
| Jun 30, 2025 | -294,000.00 |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2024 | 1.34 Mn |